USP22-JMJD8 axis promotes Lenvatinib resistance in hepatocellular carcinoma
Jinhui Guo, Jie Zhao
Topics & Concepts
LenvatinibGene knockdownCancer researchSorafenibMedicineHepatocellular carcinomaDrug resistanceApoptosisPharmacologyBiologyMicrobiologyBiochemistryCancer, Hypoxia, and MetabolismHepatocellular Carcinoma Treatment and PrognosisUbiquitin and proteasome pathways